However, the majority of NFE2 mutations identified in MPN patients do not contain a functional dimerization domain, either because of frameshift mutations that cause a premature stop, leading to a C-terminally truncated protein, or because of mutations within the dimerization domain itself. This evidence concerns the gene NFE2 and myeloproliferative neoplasm.